![Marcus A. Conant](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcus A. Conant
Corporate Officer/Principal bei The University of California, San Francisco
Aktive Positionen von Marcus A. Conant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | - | - |
Karriereverlauf von Marcus A. Conant
Ehemalige bekannte Positionen von Marcus A. Conant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Presidio Pharmaceuticals, Inc.
![]() Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ENZO BIOCHEM, INC. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ENZO BIOCHEM, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Presidio Pharmaceuticals, Inc.
![]() Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Marcus A. Conant
- Erfahrung